This is the authors' abstract. We don't add key points for this paper.
Background The COVID-19 pandemic presents challenges to substance misuse services. Patients face a higher risk of infection and transmission to others. Services were required to reconfigure quickly in response to the government lockdown. These changes had to be completed before national guidance was published.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hazan et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: